We want to keep people out of the hospital by preventing disease using vaccines and immunity enhancing therapeutics. Our patented delivery system is differentiated because it’s non-toxic, economical to make and easy to purify. We are seeking funding to complete a clinical trial for our lead influenza vaccine candidate and to test our technology in other diseases. There are many opportunities to apply our platform technology in infectious diseases, allergy and cancer.